Myovant Sciences Ltd. Principal Executive Officer David Marek's 2021 pay jumps 154% to $6.2M
Myovant Sciences Ltd. reports 2021 executive compensation
By ExecPay News
Published: July 27, 2022
Myovant Sciences Ltd. reported fiscal year 2021 executive compensation information on July 27, 2022.
In 2021, four executives at Myovant Sciences Ltd. received on average a compensation package of $4.8M, a 27% decrease compared to previous year.
David Marek, Principal Executive Officer, received $6.2M in total, which decreased by 39% compared to 2020. 39% of Marek's compensation, or $2.4M, was in stock awards. Marek also received $473K in non-equity incentive plan, $2.4M in option awards, $750K in salary, as well as $207K in other compensation.
Uneek Mehra, Principal Financial Officer, received a compensation package of $5.2M. 44% of the compensation package, or $2.3M, was in option awards.
Frank Karbe, Former Principal Financial and Accounting Officer, earned $4.5M in 2021, a 49% increase compared to previous year.
Lauren Merendino, Chief Commercial Officer, received $3.5M in 2021.
Myovant Sciences Ltd.'s fiscal year ends on March 31.